Adoptive immunotherapy for Epstein-Barr virus-related lymphoma

Leukemia and Lymphoma

Volumn 23, Issue 3-4, 1996, Pages 213-220

  Smith, Colton A ^a   Ng, Catherine Y C ^a   Loftin, Susan K ^a   Li, Congfen ^a   Heslop, Helen E ^a,b   Brenner, Malcolm K ^a,b   Rooney, Cliona M ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Bone marrow transplantation; Cytotoxic T lymphocytes; Epstein Barr virus; Immunotherapy

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ANTIVIRAL ACTIVITY; B CELL LYMPHOMA; BONE MARROW TRANSPLANTATION; CELLULAR IMMUNITY; COMPUTER ASSISTED TOMOGRAPHY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HLA MATCHING; HUMAN; HUMAN CELL; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0030447541     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054823     Document Type: Review

References (31)

1. Boyle, M. J., Sculley, T B., Penny, R. et al. (1992) The role of Epstein-Barr virus subtypes in human immunodeficiency virus-associated lymphoma. Leukemia and Lymphoma, 10, 17-23.
2. Gail, M. H., Pluda, J. M., Rabkin, C. S. et al. (1991) Projections of the incidence of Non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. Journal of the National Cancer Institute, 83, 605-701.
3. Fischer, A., Blanche, S., LeBidois, J. et al. (1991) Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. New England Journal of Medicine, 324, 1451-1455.
4. Papadopoulos, E. B., Ladanyi, M., Emanuel, D et al. (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New England Journal of Medicine, 330, 1185-1191.
5. Bourgault, I., Gomez, A., Gomard, E. and Levy, J. P. (1991) Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes. Clin. Exp. Immunol., 84, 501-507.
6. Rencher, S. D., Slobod, K. S., Smith, F. S. et al. (1994) Activity of transplanted CD8+ versus CD4+ cytotoxic T cells against Epstein-Barr virus-immortalized B cell tumors in SCID mice. Transplantation, 58, 629-633.
7. Cannon, M. J., Openshaw, P. J. M. and Askonas, B. A. (1988) Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med., 168, 1163-1168.
8. Heslop, H. E., Brenner, M. K. and Rooney, C. M. (1994) Donor T cells to treat EBV-associated lymphoma. New England Journal of Medicine, 331, 679-680.
9. Heslop, H. E., Brenner, M. K., Rooney, C. M. et al. Administration of neomycine resistance gene marked EBV specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts. Human Gene Therapy, 5, 381-397.
10. Riddell, S. R., Watanabe, K. S. and Goodrich, J. M. et al. (1992) Restoration of viral immunity in immunodeficient humans by adoptive transfer of T cell clones. Science, 257, 238-241.
11. Walter, E. A., Greenberg, P. D., Gilbert, M. J. et al. (1995) The reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New England Journal of Medicine, 333, 1038-1044.
12. Smith, C. A., Ng, C. Y. C., Heslop, H. E. et al. (1995) Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease Journal of Hematotherapy, 4, 73-79.
13. Rickinson, A. B., Rowe, M., Hart, I. J. et al. (1984) T-cell-mediated regression of spontaneous and of Epstein-Barr virus-induced B-cell transformation in vitro: studies with cyclosporin A. Cellular Immunology, 87, 646-658.
14. Young, L., Alfieri, C., Hennessy, K. et al. (1989) Expression of Epstein-Barr virus transformation-associated genes in tissues of padents with EBV lymphoproliferative disease. N. Engl J. Med., 321, 1080-1085.
15. Riddell, S. R. and Greenberg, P. D. (1990) The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expland human antigen-specific T cells. J. Immunol. Methods, 128, 189-198.
16. Wallace, L. E., Rickinson, A. B., Rowe, M. et al (1982) Stimulation of human lymphocytes with irradiated cells of the autologous Epstein Barr virus-transformed cell line I. virus-specific and nonspecific components of the cytotoxic response, Cellular Immunology, 67, 129-140.
17. Allan, D. J., Rickinson, A. B., Wallace, L. E. et al. (1982) Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line II. cytotoxic response to repeated stimulation. Cellular Immunology, 67, 141-151.
18. Khanna, R., Burrows, S. R., Kurilla, M. G. et al. (1992) Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J. Exp. Med., 176, 169-175.
19. Murray, R. J., Kurilla, M. G., Brooks, J. M. et al. (1992) Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus: implications for the immune control of EBV-positive malignancies. J. Exp. Med., 176, 157-165.
20. Brenner, M. K., Heslop, H. E , Rill, D. R. et al. (1994) Gene transfer and bone marrow transplantation. Cold Spring Harbor Symposia on Quantitative Biology, 109, 691-697.
21. Rill, D. R., Moen, R. C and Buschle, M. (1992) An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer. Blood, 79, 2694-2698.
22. Rooney, C. M., Loftin, S. K., Holladay, M. S. et al. (1995) Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease British Journal of Haematology, 89, 98-103.
23. Rooney, C. M., Smith, C. A., Ng, C. Y C. et al. (1995) Use of gene modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet, 345, 9-12.
24. Weiss, L. M., Movahed, L. A , Warnke, R. A. and Sklar, J. (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. New England Journal of Medicine, 320, 502-506.
25. Deacon, E. M., Pallesen, G., Niedobitek, G. et al (1993) Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J. Exp. Med., 177, 339-349.
26. Flomenberg, P., Babbit, J., Drobyski, W. R. et al. (1994) Increasing incidence of adenovirus disease in bone marrow transplant recipients. The Journal of Infectious Diseases, 169, 775-781.
27. Hromas, R., Cornetta, K., Srour, E, et al. (1994) Donor leukocyte infusion as therapy for life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood, 84, 1689-1690.
28. Cohen, J. I. (1991) Epstein-Bair virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine, 70, 137-160.
29. Shapiro, R. S., McClain, K., Frizzera, S. et al. (1988) Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood, 71, 1234-1238.
30. Todo, S., Tzakis, A., Reyes, J. et al. (1995) Intestinal transplantation: 4-year experience. Transplantation Proceedings, 27, 1355-1356.
31. Nalesnik, M. A. (1991) Lymphoproliferative disease in organ transplant recipients. Springer Semin. Immunopathol., 13, 199-213.